deltatrials

Myelodysplastic syndrome Trials in Tampa, United States

Conditions / Myelodysplastic syndrome / Tampa, United States

Research into Myelodysplastic syndrome spans multiple therapeutic approaches and trial phases.

30 total trials for this combination

Showing top 10 of 30 trials

Trials

NCT ID Title Status Phase
NCT01602211 INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant COMPLETED PHASE3
NCT01696461 A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor COMPLETED PHASE2
NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia ACTIVE_NOT_RECRUITING
NCT03268954 Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) COMPLETED PHASE3
NCT00285259 Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) COMPLETED PHASE2
NCT03092674 Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome COMPLETED PHASE2/PHASE3
NCT02521493 Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome ACTIVE_NOT_RECRUITING PHASE3
NCT04726241 The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study RECRUITING PHASE1/PHASE2
NCT04635384 Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test ACTIVE_NOT_RECRUITING
NCT05316701 Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies ACTIVE_NOT_RECRUITING PHASE3

Related Pages